Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mesoblast ADR Representing 10 Ord Shs MESO

Healthcare Biotechnology
Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for... see more

Recent & Breaking News (NDAQ:MESO)

Rosen, Globally Respected Investor Counsel, Announces Filing of Securities Class Action Lawsuit Against Mesoblast Limited; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESO

Newsfile October 12, 2020

MESO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Mesoblast Limited Shareholders of Class Action and Lead Plaintiff Deadline: December 7, 2020

ACCESSWIRE IA October 12, 2020

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire October 12, 2020

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA October 11, 2020

ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Mesoblast Limited; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESO

PR Newswire October 9, 2020

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA October 9, 2020

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Mesoblast Limited (MESO) Investors

Business Wire October 9, 2020

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire October 9, 2020

ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Mesoblast Limited; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESO

Business Wire October 9, 2020

MESO CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Mesoblast Limited (MESO)

Business Wire October 9, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mesoblast Limited - MESO

GlobeNewswire October 8, 2020

MESOBLAST ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Mesoblast Limited and Encourages Investors to Contact the Firm

GlobeNewswire October 8, 2020

MESO CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Mesoblast Limited

Business Wire October 8, 2020

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Mesoblast Limited (MESO) on Behalf of Investors

Business Wire October 7, 2020

The Law Offices of Frank R. Cruz Continues Its Investigation of Mesoblast Limited (MESO) on Behalf of Investors

Business Wire October 6, 2020

Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Mesoblast Limited (MESO) Investigation

ACCESSWIRE IA October 5, 2020

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Mesoblast Limited (MESO) on Behalf of Investors

Business Wire October 5, 2020

Mesoblast Receives Complete Response Letter From the FDA for Biologics License Application for Steroid-Refractory Acute Graft Versus Host Disease in Children

GlobeNewswire October 1, 2020

Mesoblast Wins 2020 Fierce Biotech Innovation of the Year Award for remestemcel-L

GlobeNewswire September 15, 2020

Data Safety Monitoring Board Recommends Continuation of Remestemcel-L Phase 3 Trial in COVID-19 Patients With Acute Respiratory Distress Syndrome

GlobeNewswire September 4, 2020